Company / Assets per Share
Nurix Therapeutics, Inc. Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$9.07
FY2025
5-year range
$7.54 / $13.74
FY2021-FY2025
Trend
-34.0%
vs FY2024
Sector context
#107 of 210
Health Care
What the data says
At $9.07, Nurix Therapeutics, Inc.'s assets per share ranks #107 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 7 years, ranging from $7.54 in FY2023 to $110.24 in FY2020.
Based on SEC 10-K filings.
9.07 in FY2025 with a 5-year CAGR of -39.3%.
Improved from $7.54 to $9.07 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -0.9%
- 5-Year CAGR
- -39.3%
- 10-Year CAGR
- -
Sector benchmark
#107 of 210 in Health CareTop 51% of 210This company $9.07 Sector average $296.79
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 34.0% year-over-year.
- Ranks #107 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.07 | -34.0% |
| FY2024 | $13.74 | +82.3% |
| FY2023 | $7.54 | -19.2% |
| FY2022 | $9.33 | -23.9% |
| FY2021 | $12.27 | -88.9% |
| FY2020 | $110.24 | +724.0% |
| FY2019 | $13.38 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026